STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $87,000 | -69.7% | 29,233 | -71.8% | 0.00% | – |
| Q1 2021 | $287,000 | -0.7% | 103,752 | -12.6% | 0.00% | – |
| Q4 2020 | $289,000 | +34.4% | 118,743 | +16.1% | 0.00% | – |
| Q3 2020 | $215,000 | -44.4% | 102,247 | 0.0% | 0.00% | – |
| Q2 2020 | $387,000 | +170.6% | 102,247 | +35.9% | 0.00% | – |
| Q1 2020 | $143,000 | -9.5% | 75,231 | 0.0% | 0.00% | – |
| Q4 2019 | $158,000 | -12.2% | 75,231 | 0.0% | 0.00% | – |
| Q3 2019 | $180,000 | -23.7% | 75,231 | 0.0% | 0.00% | – |
| Q2 2019 | $236,000 | -54.1% | 75,231 | +29.7% | 0.00% | – |
| Q1 2018 | $514,000 | +52.5% | 58,000 | +25.0% | 0.00% | – |
| Q4 2017 | $337,000 | +5.0% | 46,400 | 0.0% | 0.00% | – |
| Q3 2017 | $321,000 | -3.3% | 46,400 | 0.0% | 0.00% | – |
| Q2 2017 | $332,000 | – | 46,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |